Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP — Stella

Recruiting

Back to Hiv trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

APT Foundation, New Haven, Connecticut

Key details

Phase

Post-approval study

Sponsor

University of Connecticut

Enrollment target

~256 participants

Started

March 2023

Primary completion

January 2027

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov